Standard InChI: InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1 (Source: PubChem)
IUPAC Name: 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide (Source: PubChem)
PubChem CID: 71226662 (Source: PubChem)
SMILES String: CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5 (Source: PubChem)
Connectivity SMILES string: CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5 (Source: PubChem)
Standard InChIKey: WDENQIQQYWYTPO-IBGZPJMESA-N (Source: PubChem)
CAS Registry Number: 1420477-60-6 (Source: PubChem)
ChEBI ID: CHEBI:167707 (Source: PubChem)
ChEMBL ID: CHEMBL3707348 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID401026209 (Source: PubChem)
European Community Number: 814-272-0 (Source: PubChem)
Wikidata ID: Q23668732 (Source: PubChem)
CompTox Dashboard Compound ID: DTXCID401510462 (Source: PubChem)
WHO ATC Classification Drug Code: L01EL02 (Source: ChEMBL)
Connectivity SMILES string: CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12 (Source: ChEMBL)
International Nonproprietary Name: Acalabrutinib (Source: ChEMBL)
Japanese Adopted Name: Acalabrutinib (Source: ChEMBL)
Merck Index Name: Acalabrutinib (Source: ChEMBL)
Preferred Name: ACALABRUTINIB (Source: ChEMBL)
Standard InChI: InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1 (Source: ChEMBL)
Standard InChIKey: WDENQIQQYWYTPO-IBGZPJMESA-N (Source: ChEMBL)
US Adopted Name: Acalabrutinib (Source: ChEMBL)